SBFM Q2 2020 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15,145+399.3% YoY

Gross Profit

$9,98465.9% margin

Operating Income

-$128,569-848.9% margin

Net Income

-$907,444-5991.7% margin

EPS (Diluted)

$-1346.36

QoQ Revenue Growth

+36.4%

Cash Flow

Operating Cash Flow

-$82,016

Free Cash Flow

-$82,016

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$138,517

Total Liabilities

$665,780

Stockholders' Equity

-$527,263

Cash & Equivalents

$85,593

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15,145	$3,033	+399.3%
Gross Profit	$9,984	$1,573	+534.7%
Operating Income	-$128,569	-$66,197	-94.2%
Net Income	-$907,444	-$710,890	-27.6%